Home/Filings/4/0000899243-20-029741
4//SEC Filing

Gordon Christopher R 4

Accession 0000899243-20-029741

CIK 0001805387other

Filed

Oct 28, 8:00 PM ET

Accepted

Oct 29, 8:00 PM ET

Size

8.2 KB

Accession

0000899243-20-029741

Insider Transaction Report

Form 4
Period: 2020-10-27
Gordon Christopher R
Director10% Owner
Transactions
  • Other

    Common Stock

    2020-10-27+49,961,94350,300,063 total(indirect: See Footnotes)
  • Purchase

    Common Stock

    2020-10-27$10.00/sh+10,000,000$100,000,00060,300,063 total(indirect: See Footnotes)
Footnotes (3)
  • [F1]On October 27, 2020, Cerevel Therapeutics Holdings, Inc. (f/k/a ARYA Sciences Acquisition Corp II, the "Issuer") consummated a business combination (the "Business Combination") pursuant to which Cassidy Merger Sub 1, Inc., a wholly-owned subsidiary of the Issuer merged with and into Cerevel Therapeutics, Inc. ("Cerevel"). At the effective time of the Business Combination, each share of Cerevel outstanding as of immediately prior to the effective time was exchanged for shares of Common Stock of the Issuer based on an implied Cerevel vested equity value of $780,000,000. As a result, BC Perception Holdings, LP ("BC Perception") received 49,961,943 shares of the Issuer's Common Stock in consideration for the equity securities of Cerevel held by BC Perception prior to the Business Combination.
  • [F2]On October 27, 2020, BC Perception purchased 10,000,000 shares of the Issuer's Common Stock from the Issuer at a price of $10.00 per share.
  • [F3]Christopher Gordon is a Managing Director of Bain Capital Investors, LLC ("BCI"), the ultimate general partner of BC Perception. Voting and investment decisions with respect to securities held by BC Perception are made by the managing directors of BCI. As a result, Mr. Gordon may be deemed to share voting and dispositive power with respect to the securities held by BC Perception. Mr. Gordon disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Issuer

Cerevel Therapeutics Holdings, Inc.

CIK 0001805387

Entity typeother

Related Parties

1
  • filerCIK 0001432313

Filing Metadata

Form type
4
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 8:00 PM ET
Size
8.2 KB